Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

141 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms.
Cantoni D, Siracusano G, Mayora-Neto M, Pastori C, Fantoni T, Lytras S, Di Genova C, Hughes J, On Behalf Of The Ambulatorio Medico San Luca Villanuova Group, Lopalco L, Temperton N. Cantoni D, et al. Vaccines (Basel). 2022 Dec 27;11(1):58. doi: 10.3390/vaccines11010058. Vaccines (Basel). 2022. PMID: 36679903 Free PMC article.
Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants.
Carnell GW, Billmeier M, Vishwanath S, Suau Sans M, Wein H, George CL, Neckermann P, Del Rosario JMM, Sampson AT, Einhauser S, Aguinam ET, Ferrari M, Tonks P, Nadesalingam A, Schütz A, Huang CQ, Wells DA, Paloniemi M, Jordan I, Cantoni D, Peterhoff D, Asbach B, Sandig V, Temperton N, Kinsley R, Wagner R, Heeney JL. Carnell GW, et al. Front Immunol. 2023 Feb 23;14:1118523. doi: 10.3389/fimmu.2023.1118523. eCollection 2023. Front Immunol. 2023. PMID: 36911730 Free PMC article.
Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.
Aguinam ET, Nadesalingam A, Chan A, Smith P, Paloniemi M, Cantoni D, Gronlund J, Gronlund H, Carnell GW, Castillo-Olivares J, Temperton N, Blacklaws B, Heeney JL, Baxendale H. Aguinam ET, et al. J Allergy Clin Immunol Glob. 2023 May;2(2):100091. doi: 10.1016/j.jacig.2023.100091. Epub 2023 Mar 15. J Allergy Clin Immunol Glob. 2023. PMID: 37038555 Free PMC article.
Immunogenicity of a silica nanoparticle-based SARS-CoV-2 vaccine in mice.
Barbey C, Su J, Billmeier M, Stefan N, Bester R, Carnell G, Temperton N, Heeney J, Protzer U, Breunig M, Wagner R, Peterhoff D. Barbey C, et al. Eur J Pharm Biopharm. 2023 Nov;192:41-55. doi: 10.1016/j.ejpb.2023.09.015. Epub 2023 Sep 27. Eur J Pharm Biopharm. 2023. PMID: 37774890 Free article.
Pseudotyped Viruses for Influenza.
Del Rosario JMM, da Costa KAS, Temperton NJ. Del Rosario JMM, et al. Among authors: temperton nj. Adv Exp Med Biol. 2023;1407:153-173. doi: 10.1007/978-981-99-0113-5_8. Adv Exp Med Biol. 2023. PMID: 36920696
A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.
Vishwanath S, Carnell GW, Ferrari M, Asbach B, Billmeier M, George C, Sans MS, Nadesalingam A, Huang CQ, Paloniemi M, Stewart H, Chan A, Wells DA, Neckermann P, Peterhoff D, Einhauser S, Cantoni D, Neto MM, Jordan I, Sandig V, Tonks P, Temperton N, Frost S, Sohr K, Ballesteros MTL, Arbabi F, Geiger J, Dohmen C, Plank C, Kinsley R, Wagner R, Heeney JL. Vishwanath S, et al. Nat Biomed Eng. 2023 Sep 25. doi: 10.1038/s41551-023-01094-2. Online ahead of print. Nat Biomed Eng. 2023. PMID: 37749309
Vaccination and protective immunity to SARS-CoV-2 omicron variants in people with immunodeficiencies.
Nadesalingam A, Cantoni D, Aguinam ET, Chan AC, Paloniemi M, Ohlendorf L, George C, Carnell G, Lyall J, Ferrari M, Temperton N, Wagner R, Castillo-Olivares J, Baxendale H, Heeney JL. Nadesalingam A, et al. Lancet Microbe. 2023 Feb;4(2):e58-e59. doi: 10.1016/S2666-5247(22)00297-X. Epub 2022 Nov 1. Lancet Microbe. 2023. PMID: 36332646 Free PMC article. No abstract available.
A delicate balance between antibody evasion and ACE2 affinity for Omicron BA.2.75.
Huo J, Dijokaite-Guraliuc A, Liu C, Zhou D, Ginn HM, Das R, Supasa P, Selvaraj M, Nutalai R, Tuekprakhon A, Duyvesteyn HME, Mentzer AJ, Skelly D, Ritter TG, Amini A, Bibi S, Adele S, Johnson SA, Paterson NG, Williams MA, Hall DR, Plowright M, Newman TAH, Hornsby H, de Silva TI, Temperton N, Klenerman P, Barnes E, Dunachie SJ, Pollard AJ, Lambe T, Goulder P; OPTIC consortium; ISARIC4C consortium; Fry EE, Mongkolsapaya J, Ren J, Stuart DI, Screaton GR. Huo J, et al. Cell Rep. 2023 Jan 31;42(1):111903. doi: 10.1016/j.celrep.2022.111903. Epub 2022 Dec 14. Cell Rep. 2023. PMID: 36586406 Free PMC article.
141 results